Beyond direct tumor suppression, our work uncovers a novel dual mechanism: SDFZ‐8 not only inhibits HDAC1‐driven oncogenesis but also reprograms the tumor immune microenvironment by activating T cells, enhancing antigen presentation, and reversing macrophage‐mediated immunosuppression. Here, HDAC1 is linked to neoplasm.